Source:http://linkedlifedata.com/resource/pubmed/id/19124225
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-3
|
pubmed:dateCreated |
2009-2-3
|
pubmed:abstractText |
SUMMARY: Zonisamide (ZNS) is a multi-target antiepileptic drug reported to be efficient in the treatment of both partial and generalized seizures, with T-type Ca(2+) channel blockade being one of its proposed mechanisms of action. In this study, we systematically investigated electrophysiological effects of ZNS on cloned human Ca(v)3.1-3.3 Ca(2+) channels in a heterologous HEK-293 expression system using whole cell patch-clamp technique. Concentration-response studies were performed in the range from 5 microM to 2mM for Ca(v)3.2 Ca(2+) channels exhibiting a 15.4-30.8% reduction of Ca(2+) influx within the maximum therapeutic plasma range (50-200 microM ZNS). The other T-type Ca(2+) channel entities, Ca(v)3.1 and Ca(v)3.3, were even less sensitive to ZNS. Both voltage- and concentration-dependence of inactivation kinetics remained unchanged for Ca(v)3.2 VGCC, whereas Ca(v)3.1 and Ca(v)3.3 exhibited minor, though significant reduction of inactivation-tau. Interestingly, ZNS block of Ca(v)3.2 VGCCs was not use-dependent and remained unaffected by changes in the holding potential. Steady-state inactivation studies did not display a significant shift in steady-state availability of Ca(v)3.2 channels at 100 microM ZNS (DeltaV(1/2)=3.1mV, p=0.071). Our studies indicate that ZNS is a moderate blocker of human Ca(v)3 T-type Ca(2+) channels with little or no effect on Ca(v)3.2 Ca(2+) channel inactivation kinetics, use- and state-dependence of blockade. These results suggest that T-type Ca(2+) channel inhibition only partially contributes to the anti-absence activity of ZNS antiepileptic drug.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticonvulsants,
http://linkedlifedata.com/resource/pubmed/chemical/CACNA1G protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/CACNA1H protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/CACNA1I protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/CAV3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channels, T-Type,
http://linkedlifedata.com/resource/pubmed/chemical/Caveolin 3,
http://linkedlifedata.com/resource/pubmed/chemical/Isoxazoles,
http://linkedlifedata.com/resource/pubmed/chemical/zonisamide
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1872-6844
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
224-34
|
pubmed:meshHeading |
pubmed-meshheading:19124225-Anticonvulsants,
pubmed-meshheading:19124225-Biophysical Phenomena,
pubmed-meshheading:19124225-Biophysics,
pubmed-meshheading:19124225-Calcium Channels, T-Type,
pubmed-meshheading:19124225-Caveolin 3,
pubmed-meshheading:19124225-Cell Line, Transformed,
pubmed-meshheading:19124225-Dose-Response Relationship, Drug,
pubmed-meshheading:19124225-Electric Stimulation,
pubmed-meshheading:19124225-Humans,
pubmed-meshheading:19124225-Isoxazoles,
pubmed-meshheading:19124225-Membrane Potentials,
pubmed-meshheading:19124225-Patch-Clamp Techniques,
pubmed-meshheading:19124225-Transfection
|
pubmed:year |
2009
|
pubmed:articleTitle |
Zonisamide block of cloned human T-type voltage-gated calcium channels.
|
pubmed:affiliation |
Institute of Neurophysiology, University of Cologne, Cologne, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|